Want to join the conversation?
Pharma company $SCLN and biopharma company Soligenix said they have signed a license deal granting rights to $SCLN to develop, promote, market, distribute and sell SGX942, being developed for treating oral mucositis in patients with head and neck cancer. The deal includes China, Hong Kong and Macau, as well as Taiwan, South Korea and Vietnam.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!